Recurrence of FSGS After Kidney Transplantation in Pediatric Patients: Outcomes, Treatment Response, and the Role of HLA-DR7 (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #TH-PO1219; Pres time: Oct 22, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Treatment included intensive PF and rituximab...Graft survival was mainly determined by treatment response. HLA-DR7 was associated with higher odds of recurrence, supporting its role as a risk marker."
Clinical • Chronic Kidney Disease • Focal Segmental Glomerulosclerosis • Glomerulonephritis • Nephrology • Pediatrics • Transplantation
|
|
Paulo C. Koch Nogueira; Luciana S. Feltran; Maria Fernanda Camargo Carvalho
|